Effect of stereo and regiochemistry towards wild and multidrug resistant HIV-1 virus: viral potency of chiral PETT derivatives
- 15 May 2004
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 67 (10), 1933-1946
- https://doi.org/10.1016/j.bcp.2004.01.019
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- The HIV-1 Reverse Transcription (RT) Process as Target for RT InhibitorsMedicinal Research Reviews, 2000
- Nonnucleoside reverse transcriptase inhibitorsDrugs of the Future, 2000
- Novel Four‐Drug Salvage Treatment Regimens after Failure of a Human Immunodeficiency Virus Type 1 Protease Inhibitor–Containing Regimen: Antiviral Activity and Correlation of Baseline Phenotypic Drug Susceptibility with Virologic OutcomeThe Journal of Infectious Diseases, 1999
- The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor designStructure, 1995
- Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitorsNature Structural & Molecular Biology, 1995
- High resolution structures of HIV-1 RT from four RT–inhibitor complexesNature Structural & Molecular Biology, 1995
- Pathogenesis of human immunodeficiency virus infection.Microbiological Reviews, 1993
- HIV Inhibitors Targeted at the Reverse TranscriptaseAIDS Research and Human Retroviruses, 1992
- The Molecular Biology of Human Immunodeficiency Virus Type 1 InfectionThe New England Journal of Medicine, 1991
- Molecular Targets for AIDS TherapyScience, 1990